Enanta Pharmaceuticals Inc (ENTA)

[dewophile]

while a buyout could happen at any time, I feel like the for sale sign will be up next year if RSV trial(s) fail* and no progress w the covid PI. At that point the company would be wise to shut things down, and the value is the cash + royalty stream + the lawsuit as a wildcard. In this scenario you want to maximize the cash on hand, and I think the value would be at least 18 dollars a share if this worst case comes to pass. The chairman of the board is Bruce carter and this is basically what he did with ZGEN when their recombinant thrombin inhibitor was struggling
JMO
* This assumes they get readouts for the phase 2 RSV trials. I think they will I have heard of several RSV cases now in the NYC area and one infant I know hospitalized already and it is just the beginning of traditional RSV season
DD - I also know several people who got the RSV vaccine all got the GSK FWIW